CN1104253C - Medicine for strengthening physique and strengthening immunity - Google Patents
Medicine for strengthening physique and strengthening immunity Download PDFInfo
- Publication number
- CN1104253C CN1104253C CN99106690A CN99106690A CN1104253C CN 1104253 C CN1104253 C CN 1104253C CN 99106690 A CN99106690 A CN 99106690A CN 99106690 A CN99106690 A CN 99106690A CN 1104253 C CN1104253 C CN 1104253C
- Authority
- CN
- China
- Prior art keywords
- medicine
- organism
- strengthening
- physique
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a medicine for strengthening a physique and enhancing the immune function of an organism, which is characterized in that the present invention is prepared from active raw materials of the following percentage by weight according to a dosage per tablet: 0.1% to 99% of Tangut dragonhead, 0.1% to 80% of phellodendron bark, 0.1% to 99% of rhododendron, 0.1% to 99% of licorice root, 0.1% to 99% of conic gymnadenia tuber and 0.1% to 99% of rhodiola root. The medicine can adjust and relieve the unbalanced metaboly of oxygen free radicals in a human body, enhance the immune function of the red blood cells of an organism, and improve the partial pressure of blood oxygen in the organism. The present invention has the effects of resisting anoxia, increasing the oxygen supply of the organism tissue, improving microcirculatory and lowering blood viscosity, has a certain treatment and prevention function on patients with heart, brain and lung ischemia and anoxia diseases, and has a predominant effect on pathological symptoms of a weak physique, weakness, etc. caused by various diseases. The medicine has the advantages of high therapeutic effect and no toxic or side effect.
Description
The invention belongs to a kind of Tibetan medicine, particularly a kind of building body, the medicine of enhancing human body immunity function.
Tibetan medicine has a long history and good common people basis, and Tibetan medicine is because of its growing environment uniqueness, strong, the good drug efficacy and pollution-free of the efficacy of a drug, belongs to the pure natural plant medical material and is subjected to the favor of Tibetan people deeply.But for a certain reason, the development and use and the pharmacological research thereof of relevant Tibetan medicine also are in hysteretic state.Therefore, the medicine of how developing building body, enhancing human body immunity function and be used for the treatment of the heart, brain, ischemia of lung anoxia illness from Tibetan medicine is the target that the medical worker extremely yearns for.
China is multi-nationality country, is equipped with slightly characteristics of national medicine.Adopt fully natural green Tibetan medicine medical material building body at present, human body immunity improving power, and be used to prevent and treat the problem that some disease becomes people's concern.We studies show that, this medicine has building body, the human body immunity improving function, and be used for the physical weakness that some disease causes, weak unable, and have the effect for the treatment of the heart, brain, ischemia of lung anoxia illness concurrently.
The objective of the invention is to utilize Qinghai-Tibet pure natural Tibetan medicine, Chinese crude drug that a kind of building body is provided, the enhancing human body immunity function also is used for the treatment of the medicine of the heart, brain, ischemia of lung anoxia illness, it is used for the body weakness that some disease causes for the enhancing human body immunity function, the weak unable and heart, brain, ischemia of lung anoxia epidemic disease are suffered from, remarkable efficacy is arranged, this medicine good effect, have no side effect.
The present invention is achieved in that the Rhizoma Gymnadeniae of pure natural Qinghai-Tibet Platean local products, Herba Dracocephali tangutici, Rhododendron anthopogonoides Maxim., Cortex Phellodendri, Radix Rhodiolae, and Radix Glycyrrhizae is that raw material develops through science processing compatibility.It is characterized in that it is to make with the activated feedstock of the percentage by weight of following every consumption
Herba Dracocephali tangutici 0.1-99% Cortex Phellodendri 0.1-80%
Rhododendron 0.1-99% Radix Glycyrrhizae 0.1-99%
Rhizoma Gymnadeniae 0.1-99% Radix Rhodiolae 0.1-99%
Its best proportioning is:
Herba Dracocephali tangutici 5-50% Cortex Phellodendri 1-30%
Rhododendron 10-50% Radix Glycyrrhizae 2-50%
Rhizoma Gymnadeniae 5--50% Radix Rhodiolae 3-40%
Medicine provided by the invention can make the malonaldehyde (MDA) of body reflection oxygen-derived free radicals content obviously reduce, the ability of removing oxygen-derived free radicals strengthens, being that superoxide dismutase (SOD) and glutathion peroxidase (GSH-PX) are active raises, hematid immunity function strengthens, show that this medicine has adjusting and improvement effect to radical metabolism disorder in the human body, energy enhancing human body immunity function, improving the body blood system presses, have anti-hypoxia and improve sleep, physical strength reinforcing, the enhancing human body immunity function, and the heart, brain, ischemia of lung anoxia epidemic disease suffered from certain therapeutical effect.The effective in cure height of this medical instrument, the characteristics that have no side effect.
Manufacturing process of the present invention is a common process, promptly earlier with various medicines in proportion respectively infusion concentrate and make fluid extract, extract dry (being active ingredient) in the fluid extract, mix and add adjuvant then and can make various dosage forms such as oral liquid, capsule, tablet, powder
Below be several full implementation example of the present invention:
Embodiment 1
Herba Dracocephali tangutici 20% Cortex Phellodendri 15%
Rhododendron 20% Radix Glycyrrhizae 15%
Rhizoma Gymnadeniae 20% Radix Rhodiolae 10%
In the mixture of active ingredient, add syrup, make nourushing syrup with medicine-feeding
Embodiment 2
Herba Dracocephali tangutici 2% Cortex Phellodendri 20%
Rhododendron 50% Radix Glycyrrhizae 10%
Rhizoma Gymnadeniae 8% Radix Rhodiolae 10%
In the mixture of active ingredient, make tablet with soluble starch with medicine-feeding.
Embodiment 3 Herba Dracocephali tanguticis 30% Cortex Phellodendri 40% Rhododendron 5% Radix Glycyrrhizae 5% Rhizoma Gymnadeniae 15% Radix Rhodiolae 5% is made capsule with soluble starch in the mixture of active ingredient with medicine-feeding.
Embodiment 4 Herba Dracocephali tanguticis 25% Cortex Phellodendri 10% Rhododendron 10% Radix Glycyrrhizae 15% Rhizoma Gymnadeniae 25% Radix Rhodiolae 15% is made powder with soluble starch in the mixture of active ingredient with medicine-feeding.
Claims (2)
1, the medicine of a kind of building body, enhancing human body immunity function is characterized in that it is that following row raw materials by weight percent is made:
Rhizoma Gymnadeniae 0.1-99 %.Herba Dracocephali tangutici 0.1-99%
Rhododendron 0.1-99% Cortex Phellodendri 0.1-80%
Radix Rhodiolae 0.1-99% Radix Glycyrrhizae 0.1-99%
2, the medicine of a kind of building body according to claim 1, enhancing human body immunity function is characterized in that it is that following row raw materials by weight percent is made:
Herba Dracocephali tangutici 5-50% Cortex Phellodendri 1-30%
Rhododendron 10-50% Radix Glycyrrhizae 2-50%
Radix Rhodiolae 3-40% Rhizoma Gymnadeniae 5-50%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99106690A CN1104253C (en) | 1999-05-25 | 1999-05-25 | Medicine for strengthening physique and strengthening immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN99106690A CN1104253C (en) | 1999-05-25 | 1999-05-25 | Medicine for strengthening physique and strengthening immunity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1306857A CN1306857A (en) | 2001-08-08 |
| CN1104253C true CN1104253C (en) | 2003-04-02 |
Family
ID=5272477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN99106690A Expired - Fee Related CN1104253C (en) | 1999-05-25 | 1999-05-25 | Medicine for strengthening physique and strengthening immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1104253C (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1511520A (en) * | 2002-12-31 | 2004-07-14 | �й�ҽѧ��ѧԺҩ���о��� | Use of succinate derivative for biologically treating dementia |
| CN104920743A (en) * | 2015-07-20 | 2015-09-23 | 青海省通天河藏药制药有限责任公司 | Preparation method for anti-fatigue substitutional tea |
| CN105287723B (en) * | 2015-11-19 | 2019-08-09 | 西藏大学 | A kind of hiding schizonepeta compound essential oil and preparation method thereof |
-
1999
- 1999-05-25 CN CN99106690A patent/CN1104253C/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 西北药学杂志1993,8(1) 1993-01-01 杨纯瑜 抗衰老中草药成分在植物徉属中的存在及药理作用机理研究进展 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1306857A (en) | 2001-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111097040A (en) | Antiviral lung-heat clearing peptide | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN101143171B (en) | Traditional Chinese medicine and its preparation method and its application | |
| CN1709490A (en) | Health-care tea for reducing blood pressure and fat | |
| CN106334077A (en) | Traditional Chinese medicine prescription for treating allergic rhinitis | |
| CN1104253C (en) | Medicine for strengthening physique and strengthening immunity | |
| CN1211434A (en) | Oral liquid for resisting altitude stress and its preparation method | |
| CN100531789C (en) | Chinese medicine for treating injury | |
| CN1255150C (en) | Chinese medicine preparation for curing hyperosteogeny and its preparation method | |
| CN101669995A (en) | Composite for treatment and health care of heart cerebrovascular diseases and preparation method thereof | |
| CN1618439A (en) | Broad-specturm medicine for treating snake venom poisoning | |
| CN1176690C (en) | Medicine for treating chronic nephritis | |
| CN1275633C (en) | Chinese traditional preparation for treating prostatitis | |
| CN1062769C (en) | Medicine for anti-anoxia and treating chronic hepatitis | |
| CN1063077C (en) | Traditional Chinese medicine composition for lowering blood-lipid, and method for preparing same | |
| CN1270733C (en) | Hunai Mushroom sclerotium used for treating diabotes and its preparation | |
| CN100586453C (en) | Preparation method for Jingfukang tablet | |
| CN1291722C (en) | Use of oligoxylose in preparing medicine for treating diabetes | |
| CN1103599C (en) | Chenxia medicament for relieving asthma and its pren. tech. | |
| CN1315200A (en) | Exterior-applied medicine for treating lumbar intervertebral disk protrusion | |
| CN1686322A (en) | Blood fat reducing granules containing seed of pepper weed or flixweed tansymustard | |
| CN1168483C (en) | Heart disease treating medicine | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| Choi et al. | Clinical effects of Korean ginseng, Korean red ginseng, Chinese ginseng, and American ginseng on blood pressure in mild hypertensive subjects | |
| CN1193527A (en) | Medicine for acute diarrhea of baby and preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |